Profilo
Ian Garland is currently a Director at Ligand UK Development Ltd. He was previously the Chief Executive Officer & Executive Director at Ligand UK Ltd. from 2012 to 2018.
He was also the Chief Executive Officer at Acambis Plc in 2007, and a Director at Vernalis (R&D) Ltd. from 2009 to 2018.
Additionally, he was the Chief Financial Officer at Amarin Corp.
Plc in 2003, and a Principal at KPMG LLP from 1988 to 1995.
He was also a Principal at Pepsi-Cola North America from 1995 to 1999, and a Chief Financial Officer at Arrow Therapeutics Ltd. from 2004 to 2007.
Furthermore, he was a Principal at Medeva Plc from 1995 to 1999, and the President & Chief Operating Officer at Celltech Pharma Europe Ltd.
Posizioni attive di Ian Garland
| Società | Posizione | Inizio |
|---|---|---|
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ian Garland
| Società | Posizione | Fine |
|---|---|---|
| VERNALIS | Amministratore Delegato | 12/10/2018 |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Direttore/Membro del Consiglio | 12/10/2018 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Presidente | 01/09/2008 |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Direttore Finanziario/CFO | 01/01/2007 |
| AMARIN CORPORATION PLC | Direttore Finanziario/CFO | 01/01/2004 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pepsi-Cola North America
Pepsi-Cola North America Beverages: Non-AlcoholicConsumer Non-Durables Manufactures and markets beverage products | Consumer Non-Durables |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Medeva Plc
Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Health Technology |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Health Technology |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Celltech Pharma Europe Ltd. |
















